Loading organizations...
Hamilton Square Partners Management is an investment firm that specializes in deploying capital into innovative healthcare enterprises. The firm focuses on identifying and supporting companies that are developing novel technologies and solutions within the healthcare sector, employing a strategic investment approach to cultivate advancements and growth across the industry. Their methodology centers on understanding and capitalizing on specific opportunities within this complex market.
The firm was founded by David S. Tukey, Ph.D., who also holds the role of Chief Investment Officer. Dr. Tukey established Hamilton Square Partners Management based on the understanding that focused expertise is essential for navigating the intricacies and potential of healthcare innovation. His foundational insight guides the firm's dedicated investment strategy in this specialized area.
Hamilton Square Partners Management primarily serves its limited partners by investing in promising healthcare ventures that align with its strategic objectives. The firm’s vision is to act as a significant catalyst for progress, driving the development of transformative healthcare solutions. It aims to contribute to improved patient outcomes and systemic enhancements across the broader healthcare ecosystem by fueling impactful innovation.
Hamilton Square Partners Management has 1 tracked investment across 1 company. The latest tracked deal is $77.0M Series B in Crossbow Therapeutics in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 18, 2026 | Crossbow Therapeutics | $77.0M Series B | Arkin BIO Ventures, Taiho Ventures | BVF Partners, ELI Lilly And Company, Libbs Ventures, Lifelink, Mirae Asset Venture Investment, MPM Capital, Pfizer Ventures, Polaris Partners, Sixty Degree Capital, The Leukemia & Lymphoma Society |